ALFA Filings
Every announcement, straight from the exchange
Every Alivus Life Sciences other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Alivus Life Sciences Limited filed its Annual Secretarial Compliance Report for FY2025-26. The report confirms full regulatory compliance with no adverse observations from the practicing company secretary.